Latest filing published 11 Mar 2019 for GlaxoSmithKline plc, €209k.
Insider track record
V Whyte: trading record in brief
V Whyte appears in our data through filings on GlaxoSmithKline plc shares, published by RNS (LSE). In total, 4 filings cover trades dated from 15 February 2018 to 8 March 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 11 March 2019 came the latest disclosure, a share grant for €209k in GlaxoSmithKline plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 1 day. For comparison, UK MAR gives managers three business days to notify a trade. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to V Whyte
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,800 shares@ £15.12495.3% of flown/aISIN GB0009252882FCA-NSM:LSE20190311182400_13997969_20200326185134137_20469-12
- 888 shares@ £10.134.7% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20190222173012_13979402_20200326185109456_6421-2
- 8,239 sharesLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20190215181632_13971783_20200326185109816_13356-10
- 9,667 sharesLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20180216172538_13536896_20200330111412573_11182-11
4 of 4 declarations